Navarro Suggests Trump May Levy 232 Tariffs on Pharmaceutical Goods
2025-08-15 / Read about 0 minute
Author:小编   

White House advisor Peter Navarro hinted that President Donald Trump might impose tariffs on pharmaceutical products under Section 232 of U.S. trade law. This announcement triggered a decline in the share prices of Pfizer and UnitedHealth, whereas Amgen, Johnson & Johnson, and AstraZeneca ADR witnessed modest gains.